Shire Forecasts Higher Earnings in 2015 After NPS Acquisi

Shire Plc forecast higher earnings as the maker of drugs for rare diseases and attention deficit hyperactivity disorder gets new medicines through its acquisition of NPS Pharmaceuticals Inc.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.